High-Risk Weight Loss Increases Death Risk in Obese Patients With CKD
Trajectories of key clinical variables associated with weight loss distinguished patients with physiologic resilience vs vulnerability.
Trajectories of key clinical variables associated with weight loss distinguished patients with physiologic resilience vs vulnerability.
Treatment with the glucagon-like-peptide-1 receptor agonist yielded substantial benefits in patients with heart failure with preserved ejection fraction.
Significant reduction also seen in obesity-related cancer incidence and in cancer mortality after bariatric surgery
Mean testosterone concentration was relatively stable until age 70 years, investigators reported.
Based on body mass index, 120 million Americans would qualify to take Wegovy
In a Norwegian study of the general population, individuals with metabolic syndrome were more likely to have renal hyperfiltration and experience steeper long-term declines in glomerular filtration rate.
Clinical trial demonstrates reduction in major adverse cardiovascular events of 20 percent, drug maker says
Investigators report findings from a retrospective study of 13,081 patients undergoing radical cystectomy.
A recent literature review supports the idea that obesity needs to have an individualized, root cause approach.
Significantly lower rate of stroke within 90 days seen for ticagrelor-ASA versus clopidogrel-ASA for those carrying CYP2C19 loss-of-function allele.